Purposedetects specific antigen or antibody
A schematic of a complement fixation test

The complement fixation test is an immunological medical test that can be used to detect the presence of either specific antibody or specific antigen in a patient's serum, based on whether complement fixation occurs. It was widely used to diagnose infections, particularly with microbes that are not easily detected by culture methods, and in rheumatic diseases. However, in clinical diagnostics labs it has been largely superseded by other serological methods such as ELISA and by DNA-based methods of pathogen detection, particularly PCR.

Process

edit

The complement system is a system of serum proteins that react with antigen-antibody complexes. If this reaction occurs on a cell surface, it will result in the formation of trans-membrane pores and therefore destruction of the cell. The basic steps of a complement fixation test are as follows:[1]

  1. Serum is separated from the patient.
  2. Patients naturally have different levels of complement proteins in their serum. To negate any effects this might have on the test, the complement proteins in the patient's serum must be destroyed and replaced by a known amount of standardized complement proteins.
    1. The serum is heated in such a way that all of the complement proteins—but none of the antibodies—within it are destroyed. (This is possible because complement proteins are much more susceptible to destruction by heat than antibodies.)
    2. A known amount of standard complement proteins are added to the serum. (These proteins are frequently obtained from guinea pig serum.)
  3. The antigen of interest is added to the serum.
  4. Sheep red blood cells (sRBCs)[2] which have been pre-bound to anti-sRBC antibodies are added to the serum. The test is considered negative if the solution turns pink (ie, there is hemolysis) at this point and positive otherwise.

If the patient's serum contains antibodies against the antigen of interest, they will bind to the antigen in step 3 to form antigen-antibody complexes. The complement proteins will react with these complexes and be depleted. Thus when the sRBC-antibody complexes are added in step 4, there will be no complement left in the serum. However, if no antibodies against the antigen of interest are present, the complement will not be depleted and it will react with the sRBC-antibody complexes added in step 4, lysing the sRBCs and spilling their contents into the solution, thereby turning the solution pink.[1]

Testing for antigen

edit

While detection of antibodies is the most common test format, it is equally possible to test for the presence of antigen. In this case, the patient's serum is supplemented with specific antibody to induce formation of complexes; addition of complement and indicator sRBC is performed as before.[citation needed]

Semi-quantitative testing

edit

The test can be made quantitative by setting up a series of dilutions of patient serum and determining the highest dilution factor that will still yield a positive CF test. This dilution factor corresponds to the titer.[citation needed]

References

edit
  1. ^ a b "Animation Quiz 4 - Complement Fixation Test". highered.mheducation.com.
  2. ^ C. Vaman Rao (2005). Immunology: a textbook. Alpha Science Int'l Ltd. pp. 112–. ISBN 978-1-84265-255-8. Retrieved 3 December 2010.
edit

📚 Artikel Terkait di Wikipedia

Fixation

Complement fixation test, an immunochemical medical test Latex fixation test, a microbiological assay Fixation disparity, a vision condition Fixation

Complement system

cascade of further cleavages. The end result of this complement activation or complement fixation cascade is stimulation of phagocytes to clear foreign

Sensitization (immunology)

erythrocytes in advance of performing an immunological test such as a complement-fixation test or a Coombs test. The antibodies are bound to the cells in their

Virology

antibody–reaction has taken place in a test, other methods are needed to confirm this. Older methods included complement fixation tests, hemagglutination inhibition

August von Wassermann

Advancement of Science in Berlin-Dahlem (1913). Wassermann developed a complement fixation test for the diagnosis of syphilis in 1906, just one year after the

Wassermann test

fixation. It was the first blood test for syphilis and the first in the nontreponemal test (NTT) category. Newer NTTs, such as the RPR and VDRL tests

MCF

special forces unit of the Indian Navy Micro Complement fixation test, a high-sensitivity immunological medical test Muskegon Correctional Facility, a state

Whooping cough

direct fluorescent antibody (DFA), and serological methods (e.g. complement fixation test). The bacteria can be recovered from the person only during the